Table 2 Clinical characteristics of the 90 tissue samples from patients with breast cancer
Variable | Value |
|---|---|
Age Group, n (%) | |
< = 50 years | 26 (35.6) |
> 50 years | 47 (64.4) |
Tumor Size, n (%) | |
≤ 2.0 cm | 59 (67.0) |
> 2.0 cm | 29 (33.0) |
Histopathological Type, n (%) | |
Lobular infiltrating & rest | 18 (20.0) |
Intraductal infiltrating | 72 (80.0) |
Lymph-node Involvement, n (%) | |
Negative (Ν0) | 55 (67.1) |
Positive (Ν+) | 27 (32.9) |
Metastasis, n (%) | |
Negative | 47 (85.5) |
Positive | 8 (14.5) |
Grade, n (%) | |
Low (1–2) | 60 (73.2) |
High (3) | 22 (26.8) |
Estrogen-receptor Status, n (%) | |
Negative | 21 (23.9) |
Positive | 67 (76.1) |
Progesterone-receptor Status, n (%) | |
Negative | 46 (52.3) |
Positive | 42 (47.7) |
HER2 Overexpression Status, n (%) | |
Negative | 72 (81.8) |
Positive | 16 (18.2) |
TNBC status, n (%) | |
Yes | 17 (19.3) |
No | 71 (80.7) |